Unity Biotechnology, Inc.
Pharmaceutical Preparations · SOUTH SAN FRANCISCO · CA
High confidence (85%)
Updated Oct 18, 2026, 12:04 AM
What is happening
Derived by rule set status-rules-2026.09.7
The company deregistered its securities and stopped filing with the SEC. Companies do that when they are acquired, when they go private, and when they fail; the filing does not say which.
Latest material event: Unity Biotechnology, Inc. deregistered its securities (Jan 2, 2026)
Timeline
Every material event, newest first. History is never overwritten.
Unity Biotechnology, Inc. deregistered its securities
Jan 2, 2026
Registration withdrawn
- SEC EDGAR — “15-12G 1 d80085d1512g.htm 15-12G 15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 001-38470 UNITY BIOTECHNOLOGY, INC. (Exact name of registrant as specified in its charter) 124 Washington Street, Suite 101 Foxborough, MA 02035 (508) 543-1720 (Address, including zip code, and telephone number, including area code, of…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Pharmaceutical Preparations
- Subindustry
- —
- SEC CIK
- 0001463361
- Website
- —
- —
- Headquarters
- SOUTH SAN FRANCISCO, CA
- Also known as
- Cenexys, Inc., Forge Inc
- Legal entities
- Unity Biotechnology, Inc.
Sources
Every material source used to build this profile.
SEC Company Submissions (TIER 1 · UNVERIFIED)
Unity Biotechnology, Inc. — Pharmaceutical Preparations (SIC 2834) — SOUTH SAN FRANCISCO, CA
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
15-12G 1 d80085d1512g.htm 15-12G 15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 001-38470 UNITY BIOTECHNOLOGY, INC. (Exact name of registrant as specified in its charter) 124 Washington Street, Suite 101 Foxborough, MA 02035 (508) 543-1720 (Address, including zip code, and telephone number, including area code, of…
View source record
Status history
Every derived status, with the rule that produced it.
- NO_LONGER_LISTED → NO_LONGER_LISTEDPUBLIC_LISTING_ENDED · Sep 18, 2026, 01:32 AM
The company deregistered its securities and stopped filing with the SEC. Companies do that when they are acquired, when they go private, and when they fail; the filing does not say which.
- DISTRESS_SIGNAL → NO_LONGER_LISTEDPUBLIC_LISTING_ENDED · Sep 18, 2026, 01:14 AM
The company deregistered its securities and stopped filing with the SEC. Companies do that when they are acquired, when they go private, and when they fail; the filing does not say which.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:32 PM
The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 14, 2026, 04:46 PM
The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:54 AM
The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.